CPSC Recall in 2022: Samnyte Tattoo Numbing Creams Recalled Due to Failure to Meet Child-Resistant Packaging Requirement; Sold Exclusively at Amazon.com; Risk of Poisoning; Imported by Liu Xianli

Updated on March 25, 2026.

See the recall details below. You can also see similar information for other consumer product recalls in 2022.

Data Source: CPSC.

Recall Number: 23-070

Date: December 15, 2022

Product Name: Samnyte Tattoo Numbing Creams

Recall Description:

The recall involves Samnyte Tattoo Numbing Cream sold in 60ml and contains Lidocaine 5% with Vitamin E. The product was sold in a white tube with a flip-top closure. The drug facts label is on the back.

Hazard Description:

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children if they ingest it.

Consumer Action:

Remedy Type:

Refund, Replace

Units: About 9,000

Incidents:

None reported

Sold At:

Online at www.amazon.com from April 2022 through October 2022 for about $23.

Manufactured In:

China